Orchestra BioMed Holdings, Inc. (OBIO) stock
OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.25+1.10 (+17.89%)
Close on Nov 13, 2026Market cap $435.76MP/E –Yield –
Orchestra BioMed operating margin
Operating margin is operating income as a percentage of revenue.
Orchestra BioMed's operating margin for the twelve months ending Sep 30, 2026 was -195.4%. For fiscal 2025 it was -154.7%, against -2437.5% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -154.7% | +2282.8 |
| FY2024 | Dec 31, 2024 | -2437.5% | −571.3 |
| FY2023 | Dec 31, 2023 | -1866.2% | −941.8 |
| FY2022 | Dec 31, 2022 | -924.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -25600.0% | −23240.8 |
| Q2 FY2026 | Jun 30, 2026 | -25404.5% | −23092.7 |
| Q1 FY2026 | Mar 31, 2026 | -20069.1% | −17889.3 |
| Q4 FY2025 | Dec 31, 2025 | 21.8% | +6613.5 |
| Q3 FY2025 | Sep 30, 2025 | -2359.2% | −703.5 |
| Q2 FY2025 | Jun 30, 2025 | -2311.8% | −144.9 |
| Q1 FY2025 | Mar 31, 2025 | -2179.8% | +146.5 |
| Q4 FY2024 | Dec 31, 2024 | -6591.7% | −1828.0 |
| Q3 FY2024 | Sep 30, 2024 | -1655.7% | +1810.6 |
| Q2 FY2024 | Jun 30, 2024 | -2167.0% | −751.0 |
| Q1 FY2024 | Mar 31, 2024 | -2326.3% | −1334.5 |
| Q4 FY2023 | Dec 31, 2023 | -4763.7% | −3872.7 |
| Q3 FY2023 | Sep 30, 2023 | -3466.3% | −2600.7 |
| Q2 FY2023 | Jun 30, 2023 | -1416.0% | +487.8 |
| Q1 FY2023 | Mar 31, 2023 | -991.8% | −399.7 |
| Q4 FY2022 | Dec 31, 2022 | -891.0% | – |
| Q3 FY2022 | Sep 30, 2022 | -865.6% | – |
| Q2 FY2022 | Jun 30, 2022 | -1903.7% | – |
| Q1 FY2022 | Mar 31, 2022 | -592.1% | – |
See a number that looks wrong?